Literature DB >> 16860512

Reliability of semiquantitative determination of procalcitonin serum concentrations in neonates.

Agnieszka Kordek1, Wojciech Podraza, Ryszard Czajka.   

Abstract

We studied the diagnostic usefulness of semiquantitative determination of procalcitonin (PCT) concentrations in neonatal serum by reference to a quantitative method. We compared 302 results of PCT measurements in 151 samples of venous blood collected during the 1st 7 days of life. The semiquantitative BRAHMS PCT-Q test and the quantitative immunoluminometric LUMItest were compared with Cohen's kappa as a measure of concordance. Concordance was revealed for 28.4% of samples, whereas 11.9% showed total disagreement. Concordance between both methods reached 88% when results from the next (lower or higher) category were included. The weighted kappa value was 0.235, indicative of satisfactory agreement between both methods. The semiquantitative BRAHMS PCT-Q test reveals satisfactory concordance with the quantitative method when results in the next category are included to account for readout error. The semiquantitative test is rapid, easy to use, and helpful as a supportive test when the quantitative assay is not available.

Mesh:

Substances:

Year:  2006        PMID: 16860512     DOI: 10.1016/j.diagmicrobio.2006.06.001

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  5 in total

1.  The role of procalcitonin as a marker of diabetic foot ulcer infection.

Authors:  Mafalda Massara; Giovanni De Caridi; Raffaele Serra; David Barillà; Andrea Cutrupi; Alberto Volpe; Francesco Cutrupi; Antonino Alberti; Pietro Volpe
Journal:  Int Wound J       Date:  2015-10-28       Impact factor: 3.315

2.  Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study.

Authors:  A Jeandrot; J-L Richard; C Combescure; N Jourdan; S Finge; M Rodier; P Corbeau; A Sotto; J-P Lavigne
Journal:  Diabetologia       Date:  2007-10-13       Impact factor: 10.122

3.  Use of a semiquantitative procalcitonin kit for evaluating severity and predicting mortality in patients with sepsis.

Authors:  Tsuneaki Kenzaka; Masanobu Okayama; Shigehiro Kuroki; Miho Fukui; Shinsuke Yahata; Hiroki Hayashi; Akihito Kitao; Eiji Kajii; Masayoshi Hashimoto
Journal:  Int J Gen Med       Date:  2012-05-31

4.  Pro-Calcitonin, Erythrocyte Sedimentation Rate and C - reactive Protein in Predicting Diabetic Foot Ulcer Characteristics; a Cross Sectional Study.

Authors:  Fahimeh Hadavand; Atefeh Amouzegar; Hessam Amid
Journal:  Arch Acad Emerg Med       Date:  2019-07-10

5.  Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria.

Authors:  Dennis A Hesselink; Jan-Steven Burgerhart; Hanna Bosmans-Timmerarends; Pieter Petit; Perry J J van Genderen
Journal:  Malar J       Date:  2009-09-01       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.